Latest Articles

Publication Date
HEXACHLOROBENZENE AND CHLORPYRIFOS, ENVIRONMENTAL POLLUTANTS THAT DISRUPT THE ENDOCRINE SYSTEM, PROMOTE ANGIOGENESIS ASSOCIATED WITH ENDOMETRIOSIS.

Endometriosis defined by the growth of endometrial tissues outside the uterus, affects women of reproductive age. A critical process in endometriosis progression, angiogenesis involves endothelial cell migration, proliferation and tube …

Published: June 5, 2026, midnight
Gut microbiota dysbiosis in endometriosis: mechanistic insights and gut microbiota-targeted therapeutic strategies.

Endometriosis (EMs) is a prevalent, estrogen-dependent gynecological disorder characterized by the ectopic implantation and proliferation of endometrial-like tissue outside the uterine cavity, affecting approximately 10% of reproductive-aged women globally. Despite …

Published: June 5, 2026, midnight
Comparative post-marketing reporting signals of elagolix and myfembree in endometriosis: a FAERS pharmacovigilance study.

Elagolix and Myfembree are gonadotropin-releasing hormone (GnRH)-pathway therapies used for endometriosis, but their post-marketing safety reporting patterns remain incompletely characterized. Because spontaneous reporting databases are susceptible to reporting bias and …

Published: June 5, 2026, midnight
Mesonephric-like adenocarcinoma as an unexpected histological result after fertility saving procedure for presumed adenomyosis: a case report.

We report an unexpected case of mesonephric-like adenocarcinoma initially treated as a diffuse adenomyosis in a patient presenting with primary infertility. The aim of this report is to raise clinical …

Published: June 5, 2026, midnight
Deep Dyspareunia One Year After Nerve-Sparing Endometriosis Surgery: An Observational Study Highlighting Undesirable Outcomes.

Background/Objectives: This study evaluates the 1-year follow-up outcomes after minimally invasive nerve-sparing surgery for the complete excision of deep endometriosis (DE), with a specific focus on deep dyspareunia. Cases with …

Published: June 5, 2026, midnight
She chopped off her lashes to show her product. Now Xali Organics is doing $20 million in revenue - SmartCompany

She chopped off her lashes to show her product. Now Xali Organics is doing $20 million in revenue SmartCompany

Published: June 4, 2026, 11:58 p.m.
A drug for endometriosis and breast cancer leaves the PBS - but remains for prostate cancer - RUSSH

A drug for endometriosis and breast cancer leaves the PBS - but remains for prostate cancer RUSSH

Published: June 4, 2026, 11:21 p.m.
Noelle Cloven, MD, on RAINFOL-03: Actively Recruiting Trial in Pretreated Endometrial Cancer - The ASCO Post

Noelle Cloven, MD, on RAINFOL-03: Actively Recruiting Trial in Pretreated Endometrial Cancer The ASCO Post

Published: June 4, 2026, 10:12 p.m.
Marilyn Monroe Doc Shines Light on Her Hidden Endometriosis Battle - The Daily Beast

Marilyn Monroe Doc Shines Light on Her Hidden Endometriosis Battle The Daily Beast

Published: June 4, 2026, 9:58 p.m.
Marilyn Monroe Doc Shines Light on Her Hidden Health Battle - The Daily Beast

Marilyn Monroe Doc Shines Light on Her Hidden Health Battle The Daily Beast

Published: June 4, 2026, 9:58 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!